Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Capstone Therapeutics Corp. (CAPS) had Debt to Capital Ratio of 0.21 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$13.65M |
|
$-2.01M |
|
$10.40M |
|
$3.25M |
|
$14.42M |
|
$-0.77M |
|
$-1.25M |
|
$-2.01M |
|
$-2.01M |
|
$-2.01M |
|
$-2.01M |
|
$-2.01M |
|
$-2.01M |
|
$-0.77M |
|
$-0.40M |
|
5.70M |
|
5.70M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$19.11M |
|
$1.70M |
|
$39.37M |
|
$58.48M |
|
$20.02M |
|
$7.23M |
|
$11.31M |
|
$31.33M |
|
$25.19M |
|
$0.77M |
|
$27.16M |
|
6.31M |
|
| Cash Flow Statement Financials | |
$-3.99M |
|
$-2.44M |
|
$7.15M |
|
$0.01M |
|
$0.73M |
|
$0.72M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.95 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.21 |
0.71 |
|
23.83% |
|
-5.62% |
|
-5.62% |
|
-- |
|
-14.75% |
|
-14.75% |
|
$-3.99M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.85 |
|
2.37 |
|
38.04 |
|
-8.00% |
|
-262.24% |
|
-3.44% |
|
-5.86% |
|
$4.31 |
|
$-0.70 |
|
$-0.70 |
|